Next, to validate PRMT5 expression under hypoxia, we performed quantitative RT-PCR (qRT-PCR) and immunoblotting to understand PRMT5 gene and protein expression in two breast cancer cell lines MCF7 and MDA-MB-231 subjected to hypoxia. The gene discussed is PRMT5; the disease is breast cancer.